| Bid Price | 12.00p | High Price | 12.75p |
|---|
| Ask Price | 12.50p | Low Price | 11.80p |
|---|
| Open Price | 12.75p | Spread | 4.00% |
|---|
| Prev Close | 12.88p | Volume | 1,599,153 |
|---|
Creo Medical Group PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Mar 26, 2025 | 13.00 | 13.24 | 12.75 | 12.88 | 360,594 |
| Mar 25, 2025 | 13.13 | 13.25 | 12.82 | 13.13 | 110,121 |
| Mar 24, 2025 | 13.13 | 13.25 | 13.00 | 13.13 | 229,895 |
| Mar 21, 2025 | 13.13 | 13.25 | 13.00 | 13.13 | 279,959 |
Creo Medical Group PLC Information
| Name | Creo Medical Group PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BZ1BLL44 | Epic | CREO |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Medical Devices | Sector | Healthcare |
|---|
| EMS | 30,000 | Trading Status | Closed |
|---|
| Shares in Issue | 412.47 m | Prev Close | 12.88p |
|---|
| PE Ratio | | Market Cap | £50.53 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.03 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.188294 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 3.242424 | Quick Ratio | 1.989899 |
|---|
Creo Medical Group PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 28/01/25 | BUY | Craig Gulliford | CEO | 9,424 @ £0.00 | £9.00 |
| 28/01/25 | BUY | Craig Gulliford | CEO | 4,712 @ £0.19 | £900.00 |
| 28/01/25 | BUY | Christopher Hancock | ED | 4,712 @ £0.19 | £900.00 |
| 28/01/25 | BUY | Christopher Hancock | ED | 9,424 @ £0.00 | £9.00 |
| 28/01/25 | BUY | Richard Rees | FD | 9,424 @ £0.00 | £9.00 |
| 28/01/25 | BUY | Richard Rees | FD | 4,712 @ £0.19 | £900.00 |
| 16/12/24 | BUY | Kevin Crofton | CH | 1,179,000 @ £0.17 | £200,607.00 |
| 24/10/24 | BUY | Richard Rees | FD | 76,740 @ £0.20 | £15,360.00 |
| 24/10/24 | SELL | Richard Rees | FD | 174,740 @ £0.20 | £34,948.00 |
| 24/10/24 | BUY | Richard Rees | FD | 98,000 @ £0.20 | £19,615.00 |
Creo Medical Group PLC News
